Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Malaria Vaccine Production and Support Services


What services does this resource provide?

The Malaria Vaccine Production and Support Services program provides preclinical and nonclinical services in support of malaria vaccine development, including

  • Development, characterization, and production of limited quantities of clinical grade material for lead candidates for malaria vaccines
  • Development of processes to identify optimal production and purification strategies for clinical-grade immunogens or other vaccine components
  • Development of assays and reagents for product evaluation
  • Formulation and production of pilot lots of clinical trial material
  • Regulatory support for compiling documentation necessary for submission of an Investigational New Drug (IND) application and/or Master Files to the Food and Drug Administration (FDA).

As appropriate, studies may be conducted in compliance with GLP (Good Laboratory Practice) or GMP (Good Manufacturing Practice).

Note: Resources are limited and intended to fill critical gaps and are not to be the sole source of product development. Preliminary data to support program participation are required.

Where are services provided?

Services are provided by Science Applications International Corporation (SAIC) and subcontractors.


Last Updated November 26, 2012